Pfizer Inc
PFE· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $12.09B | $12.36B | $12.64B | $12.95B |
| Net Income | $2.13B | $2.67B | $2.59B | $3.21B |
| EPS Diluted | $0.34 |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.42 |
| $0.39 |
| $0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.